Engaging communities on health research
Community and public engagement not only allows researchers to give information and receive feedback, it can be embedded in a research project from the beginning, from protocol development to consent documents. Relationship and trust building is a continuous process, a skill that researchers need to improve as it will eventually benefit the community where they reside.
Head of Community Engagement
I Head the Community Engagement Platform at the KEMRI Wellcome Trust Research Programme (KWTRP). Community engagement aims at strengthening relations and building mutual understanding between researchers and communities in all KWTRP research sites. I work with an experienced team of 8 community liaison staff, who directly implement engagement activities.
My background is in Health and Strategic Behaviour Change Communication, Social Marketing and more recently Science Communication. My primary role involves developing best practice strategies for the involvement of communities and publics in research work across the different KWTRP sites, through innovative engagement initiatives. I am also responsible for mentoring and building capacity of community liaison and research staff in community and public engagement. Additionally, I play a role in the monitoring and evaluation of our engagement activities, including sharing lessons learnt across the globe. I provide guidance in the development of public engagement grant proposals and support implementation of funded initiatives.
My involvement in health, science and communities stems from over 10 years of experience in HIV, Malaria and Child Health across Kenya. I am currently driven by an interest in how to develop meaningful interactions between Researchers and Communities in LMICs: not only ensuring that community views and perspectives influence the conduct of research, but also that communities can be inspired by researchers from the region, and scientists by the lessons of quality science communication.
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
Hamaluba M. et al, (2023), Wellcome Open Research, 8, 182 - 182
A global core outcome measurement set for snakebite clinical trials
Abouyannis M. et al, (2023), The Lancet Global Health, 11, e296 - e300
A network of empirical ethics teams embedded in research programmes across multiple sites: opportunities and challenges in contributing to COVID-19 research and responses
Ngwenya N. et al, (2023)
A rapid review of community engagement and informed consent processes for adaptive platform trials and alternative design trials for public health emergencies.
Davies A. et al, (2023), Wellcome open research, 8
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)
Abouyannis M. et al, (2022), Wellcome Open Research, 7, 90 - 90